Gut microbial signatures and stability are associated with a co-diagnosis of endometriosis and inflammatory bowel disease

Read full text Summarise with VIRAT
Authors: Gabrielle K. Damm, Fan Zhang, Sabrina Koentgen, Thisun C. Jayawardana, Yashar Houshyar, Sophina Read, George Condous, Fatima El‐Assaad, Georgina Louise Hold
Cited by: 0
References: 57

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Emerging evidence suggests that the gut microbiota plays a crucial role in endometriosis (Endo) and inflammatory bowel disease (IBD). This study aimed to explore gut microbial signatures in women with either or both conditions, compared to healthy controls. Fecal samples underwent 16S rRNA sequencing to profile the gut microbiome. Endo-IBD patients had the most profound alterations including reduced microbial richness and evenness as well as bacterial signature changes. Specific bacteria taxa, including Akkermansia and Alistipes , were notably depleted in Endo-IBD patients, suggesting a compromised gut barrier and heightened inflammatory potential. Conversely, Blautia was enriched in Endo-IBD patients. Longitudinal microbiome assessment indicated a persistent dysbiotic signature in Endo-IBD and IBD groups, with microbial instability correlating with disease severity. The findings highlight an intensified impact of having a diagnosis of both conditions and further highlights the potential for microbiome-based diagnostics and the design of personalized interventions to restore microbial balance.

Fields of Study & Subjects

Gut microbiota and health Endometriosis Research and Treatment Inflammatory Bowel Disease

Publication details

Journal / source
iScience
Volume
29
Issue
4
Pages
115437–115437
Publication date
21 March 2026
Language
EN